Singapore Airlines said it plans to have a crew with the required level of vaccinations on its flights to Australia, India and certain parts of the Middle East over the next three months.
Singapore Airlines said it also plans to begin certifying in-flight outbreaks of other ailments in Singapore that typically have resulted in people being barred from flying: dengue fever and Middle East respiratory syndrome coronavirus. Those arrangements will take place in coordination with the U.S. Centers for Disease Control and Prevention.
Singapore Airlines had said in September that it had barred crew members in the U.S. and Australia from flying because they were carrying malaria, a disease that is naturally limited to Africa and Asia and which currently has no known cure. But Singapore Airlines said today that there is “growing evidence that the large majority of people infected with malaria are not clinically ill,” and that, in some cases, medication for malaria can prevent workers from getting sick.
Singapore Airlines said that its behavior has been consistent with other airlines, such as Singapore’s rival Singapore Airlines and Malaysia Airlines, who have had limited problems with the Ebola virus.
The airline also said today that it is testing cabin crew and pilots in Singapore for the illness Lyme disease. That ailment can cause fever, headache, fatigue and general muscle weakness.
Singapore Airlines said it would be test the cabin crew and pilots at the airline’s new “healthy learning center” in Mövenpick Park Hotel Singapore for the disease. The employees will be tested and retested before Singapore Airlines begins certifying them to fly.
New Zealand’s Air New Zealand is also testing its staff for Lyme disease and has reported no cases.